INDICAID COVID-19 Antigen Rapid Test, FDA EUA-Authorized OTC, HSA/FSA
12 sold in last 24 hours
- FDA EUA AUTHORIZED & HSA / FSA ELIGIBLE – This at-home COVID-19 rapid antigen test is FDA Emergency Use Authorized to detect COVID-19 and its latest variants. Eligible for HSA/FSA reimbursement, making it a convenient and cost-effective testing solution.
- TRUSTED ACCURACY & RELIABILITY – With over 45 million INDICAID tests sold across 30+ countries, the INDICAID COVID test is trusted worldwide for its precision and accuracy.
- CONVENIENT & EASY TO USE – Designed for on-the-go testing with a compact package perfect for travel, school, work, and home. Requires only a shallow nasal swab and can be completed in four simple steps.
- FAMILY FRIENDLY FOR AGES 2+ – Self-administered for individuals 15+, while children aged 2-14 require adult assistance.
Estimated shipping
Select a product to estimate shipping.Important information
Directions
Gentle Nasal Swap
Legal Disclaimer
This product has not been FDA cleared or approved; but has been authorized by FDA under an EUA; This product has been authorized only for the detection of proteins from SARS- CoV-2, not for any other viruses or pathogens. An anterior nasal swab sample can be self-collected by an individual 14 years and older. Children age 2 to 13 years should be tested by an adult. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb3(b)(1), unless the declaration is terminated, or authorization is revoked sooner.
Product details
| Main Specification | |
|---|---|
| Gamintojas | Indicaid |
| Prekės ženklas | Indicaid |
| Produkto matmenys | 1.97 x 0.79 x 0.16 inches |
| Svoris | 1.57 ounces |
| Others | |
| Data pirmą kartą prieinama | 2022 m. or July 18 |
| Produkto tipas | Clinical Diagnostic Test Kits |